202, 1201-5th Street SW
Calgary, AB T2R 0Y6
Canada
403 910 5140
https://www.willowbio.com
Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 19
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Dr. Chris Savile | President, Director & CEO | 333,69k | N/A | N/A |
Mr. Travis Doupe | Chief Financial Officer | 256,43k | N/A | 1972 |
Dr. Trish Choudhary | Senior Vice President of Research & Development | 228,87k | N/A | N/A |
Mr. Troy T. Talkkari | Vice President of Corporate Development | 142,41k | N/A | N/A |
Mr. Sanjib Singh Gill L.L.B. | Corporate Secretary | N/A | N/A | 1976 |
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.
Willow Biosciences Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.